Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)
CUSIP: 007002108
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, par value $0.0001
- Shares outstanding
- 9,599,852
- Total 13F shares
- 9,536,513
- Share change
- +472,600
- Total reported value
- $133,985,000
- Price per share
- $14.05
- Number of holders
- 39
- Value change
- +$6,730,351
- Number of buys
- 24
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 007002108?
CUSIP 007002108 identifies ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 007002108:
Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
70%
|
6,708,507
|
$79,764,000 | — | 30 Sep 2020 | |
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
|
Company |
6.9%
|
662,676
|
$7,879,000 | — | 30 Sep 2020 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
4.3%
|
415,189
|
$4,937,000 | — | 30 Sep 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
2.9%
|
274,277
|
$3,261,000 | — | 30 Sep 2020 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
1.9%
|
181,626
|
$2,159,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.4%
|
134,060
|
$1,594,000 | — | 30 Sep 2020 | |
| Artal Group S.A. |
13F
|
Company |
1.3%
|
129,335
|
$1,538,000 | — | 30 Sep 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.1%
|
107,167
|
$1,274,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.98%
|
93,803
|
$1,115,000 | — | 30 Sep 2020 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.7%
|
67,577
|
$803,000 | — | 30 Sep 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.42%
|
40,566
|
$482,000 | — | 30 Sep 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.34%
|
32,650
|
$388,000 | — | 30 Sep 2020 | |
| AWH Capital, L.P. |
13F
|
Company |
0.31%
|
30,000
|
$357,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
28,821
|
$342,000 | — | 30 Sep 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.29%
|
27,497
|
$327,000 | — | 30 Sep 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
24,683
|
$293,000 | — | 30 Sep 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
24,286
|
$289,000 | — | 30 Sep 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.16%
|
15,466
|
$184,000 | — | 30 Sep 2020 | |
| Edge Wealth Management LLC |
13F
|
Company |
0.14%
|
13,145
|
$156,000 | — | 30 Sep 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.13%
|
12,294
|
$146,000 | — | 30 Sep 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
10,224
|
$122,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
9,670
|
$115,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
2,340
|
$28,000 | — | 30 Sep 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
2,318
|
$28,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,400
|
$17,000 | — | 30 Sep 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
886
|
$10,000 | — | 30 Sep 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
305
|
$4,000 | — | 30 Sep 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
261
|
$3,000 | — | 30 Sep 2020 | |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC |
13F
|
Company |
0%
|
50
|
$1,000 | — | 30 Sep 2020 |
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q4 2020
As of 31 Dec 2020,
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,536,513 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Johnson & Johnson Innovation - JJDC, Inc., VANGUARD GROUP INC, Nantahala Capital Management, LLC, BlackRock Inc., BAILLIE GIFFORD & CO, Ikarian Capital, LLC, Artal Group S.A., J. Goldman & Co LP, and DAFNA Capital Management LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
28
Q4 2020 holders
39
Holder diff
11
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.